echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Alzheimers Dement: Jia Jianping's team found biomarkers that predict Alzheimer's disease five to seven years in advance!

    Alzheimers Dement: Jia Jianping's team found biomarkers that predict Alzheimer's disease five to seven years in advance!

    • Last Update: 2020-09-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Alzheimer's disease has become one of the diseases seriously endangering the health and quality of life of the world's elderly, reporters recently learned from the Capital Medical University Xuanwu Hospital, the hospital Jia Jianping team found that the symptoms can be predicted 5 to 7 years before the emergence of biological markers of Alzheimer's disease.
    Jia Jianping said there is no effective drug to cure Alzheimer's disease, and several Alzheimer's drugs have failed in clinical trials, possibly because the subjects are at a late stage of their illness.
    "If a patient is intervened in the early stages of Alzheimer's disease or even during the asymptomatic period, clinical symptoms may be delayed, so it is critical that accurate diagnosis can be made in the early or even asymptomatic stages of Alzheimer's disease, which is a new way of thinking for the prevention and treatment of Alzheimer's disease today."
    , " said Professor Jia Jianping.
    learned that the team collected 739 subjects from people with normal cognitive function five to seven years ago and found and validated exosome synactin as a biomarker for predicting Alzheimer's disease and mild cognitive impairment five to seven years before the onset of cognitive impairment.
    the study was further validated by subjects in familial Alzheimer's cohorts, suggesting that tests related to the biomarkers above could predict Alzheimer's disease five to seven years in advance.
    The effective diagnosis of the early or asymptomatic stage of Alzheimer's disease can gain time for its ultra-early intervention, thereby increasing the effectiveness of treatment and reducing the incidence of the disease," said Jia Jianping.
    " research paper, "Exosome Neurogenic Exosynol Synut Protein Predicts Asymptomatic Periods of Alzheimer's Disease," was published online August 10, 2020 in the international medical journal Alzheimer's disease and Alzheimer's.
    DOI: doi.org/10.1002/alz.12166.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.